Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of

Vladimir Tatochenko1, Sergey Sidorenko, Leila Namazova-Baranova

  • 1Scientific Center of Children Health, Russian Academy of Medical Science, 2/62, Lomonosovskiy avenue, Moscow, Russia.

Expert Review of Vaccines
|December 20, 2013
PubMed

Insights

Pneumococcal conjugate vaccines (PCVs) are recommended worldwide. This review of Russian studies highlights prevalent pneumococcal serotypes, informing potential disease reduction through PCV use in national immunization programs.

Area of Science:

  • * Epidemiology and Public Health
  • * Infectious Diseases
  • * Vaccinology

Background:

  • * The World Health Organization (WHO) recommends pneumococcal conjugate vaccines (PCVs) for global childhood immunization.
  • * Russia is considering PCVs for its National Immunization Programs, necessitating data on pneumococcal serotype distribution.
  • * Understanding serotype prevalence is crucial for estimating the potential impact of PCVs on disease burden.

Purpose of the Study:

  • * To review recent epidemiological studies on pneumococcal serotype distribution in Russia.
  • * To identify the most prevalent pneumococcal serotypes across various studies and isolate types.
  • * To assess the potential impact of PCV10 and PCV13 on disease reduction in Russia.

Main Methods:

  • * Systematic review of eight recent epidemiological studies on pneumococcal serotype distribution in Russia.
  • * Analysis of serotype prevalence data from diverse sources, including acute otitis media (AOM), community-acquired pneumonia (CAP), and nasopharyngeal isolates.
  • * Evaluation of antibiotic resistance patterns associated with specific serotypes.

Main Results:

  • * Serotypes 6B, 14, 19F, and 23F were consistently the most prevalent across reviewed studies.
  • * Serotype 3 was found to be relatively common, and serotype 19A showed significant prevalence in AOM, CAP, nasopharyngeal isolates, and antibiotic-resistant strains.
  • * PCV10 and PCV13 demonstrated varying serotype coverage, with differences up to 26%.

Conclusions:

  • * The current pneumococcal serotype distribution in Russia suggests that widespread PCV implementation could significantly decrease the burden of pneumococcal diseases.
  • * Serotype 19A is a notable target due to its prevalence in invasive and non-invasive infections and association with antibiotic resistance.
  • * Data-driven decisions on PCV selection (e.g., PCV10 vs. PCV13) are important for maximizing disease prevention in Russia.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K